nach oben

Erschienen in:

06.02.2020 | Original Article

Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096)

verfasst von: Carina S. Cardoso, Daiany P. B. Silva, Dayane M. Silva, Iziara F. Florentino, James O. Fajemiroye, Lorrane K. S. Moreira, José P. Vasconcelos, Germán Sanz, Boniek G. Vaz, Luciano M. Lião, Danilo da S. Lima, Fernanda Cristina A. dos Santos, Ricardo Menegatti, Elson A. Costa

Erschienen in: Inflammopharmacology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to design, synthesize and evaluate the potential analgesic and anti-inflammatory effects of 5-[1-(4-fluorphenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole—(LQFM-096: a new triazole compound) as well as to elucidate its possible mechanisms of action. The oral administration of LQFM-096 (10, 20 or 40 mg/kg) decreased the number of writhing in mice. At the dose of 20 mg/kg, LQFM-096 reduced the licking time at both neurogenic and inflammatory phases of the formalin test. Pretreatment with naloxone (3 mg/kg) and glibenclamide (3 mg/kg) attenuated the antinociceptive effect of LQFM-096 in the first phase of the formalin test. At the dose of 20 mg/kg, LQFM-096 also decreased the licking time in the acidified saline-induced and capsaicin-induced nociception. This effect was blocked by naloxone (3 mg/kg) pretreatment prior to the administration of LQFM-096. In addition, LQFM-096 inhibited hyperalgesia induced by carrageenan and PGE2. Naloxone (3 mg/kg) attenuated the effect of LQFM-096 through disinhibition of PGE2-induced hyperalgesia. The anti-inflammatory effect of LQFM-096 was demonstrated in carrageenan-induced oedema or pleurisy as well as CFA-induced arthritis. The hyperalgesia and cellular migration in CFA-induced arthritis were reduced significantly. Altogether, these findings suggest antinociceptive effect of LQFM-096 and implicate the modulation of ASICs/TRPV1 channels by opioid/KATP pathway. The anti-inflammatory effect of LQFM-096 was mediated by a reduction in oedema, leukocytes migration, TNF-α, PGE₂ levels and myeloperoxidase activity.

Nur mit Berechtigung zugänglich

Alterman M, Hallberg A (2000) Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides. J Org Chem 65(23):7984–7989. https://doi.org/10.1021/jo0009954 CrossRefPubMed

Anseloni VCZ, Ennis M, Lidow MS (2003) Optimization of the mechanical nociceptive threshold testing with the Randall-Selitto assay. J Neurosci Met 13:93–97. https://doi.org/10.1016/S0165-0270(03)00241-3 CrossRef

Baggio CH, Freitas CS, Marcon R, Werner MF, Rae GA et al (2012) Antinociception of b-d-glucan from Pleurotus pulmuonarius is possible related to protein kinaseinhibition. Int Biol Macromol 50:872–877CrossRef

Barbosa FL, Mori LS, Riva D, Stefanello MÉ, Zampronio AR (2013) Antinociceptive and anti-inflammatory activities of the ethanolic extract, fractions and 8-methoxylapachenol from Sinningia allagophylla tubers. Basic Clin Pharmacol Toxicol 113:1–7CrossRef

Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R et al (2008) Opioid complications and side effects. Pain Physician 11:S105–S120PubMed

Cai Q, Qiu C, Qiu F, Liu T, Qu Z et al (2014) Morphine inhibits acid-sensing ion channel currents in rat dorsal root ganglion neurons. Brain Res 1554:12–20. https://doi.org/10.1016/j.brainres.2014.01.042 CrossRefPubMed

Campbell VC, Welch SP (2001) The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids. Eur J Pharmacol 417(1–2):91–98CrossRef

Chandy RL, Moore PK (1998) Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 37(1):37–43CrossRef

Chopade AR, Sayyad FJ (2013) Antinociceptive effect of Phyllanthus fraternus extract in complete Freund’s adjuvant induced chronic pain in mice. Biomed Aging Pathol 3:235–240CrossRef

Costa EA, Lino RC, Gomes MN, Nascimento MNM, Florentino IF et al (2013) Anti-inflammatory and antinociceptive activities of LQFM 002—a 4-nerolidylcatechol derivate. Life Sci 92:237–244. https://doi.org/10.1016/j.lfs.2012.12.003 CrossRefPubMed

Deval E, Lingueglia E (2015) Acid-sensing ion channels and nociception in the peripheral and central nervous systems. Neuropharmacology 94:49–57. https://doi.org/10.1016/j.neuropharm.2015.02.009 CrossRefPubMed

Deval E, Gasull X, Noël J, Salinas M, Baron A et al (2010) Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther 128:549–558. https://doi.org/10.1016/j.pharmthera.2010.08.006 CrossRefPubMed

Dheer D, Singh V, Shankar R (2017) Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 71:30–54CrossRef

Di Rosa M (1972) Biological properties of carrageenan. J Pharmacol 24(2):89–102CrossRef

Endres-Becker J, Heppenstall PA, Mousa SA, Labuz D, Oksche A et al (2007) Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 71:12–18. https://doi.org/10.1124/mol.106.026740 CrossRefPubMed

Fein A (2011) Nociceptores: as células que sentem dor. Tradução de PETROV, P.; FRANCISCHI, J. N.; FERREIRA, S. H. Ribeirão Preto/SP. 2011. Disponível em: http://cell.uchc.edu/pdf/fein/nociceptors_fein_2012.pdf

Florentino IF, Silva DPB, Silva DM, Cardoso CS, Moreira ALE, Borges CL, Soares CMA, Galdino PM, Lião LM, Ghedini PC, Menegatti R, Costa EA (2017) Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: the role of nitric oxide. Nitric Oxide 69:35–44. https://doi.org/10.1016/j.niox.2017.04.006 CrossRefPubMed

Giorno TBS, Da Silva BV, Pinto AC, Fernandes PD (2016) Antinociceptive effect and mechanismof action of isatin, N-methyl isatin and oxopropyl isatin in mice. Life Sci 15:189–198CrossRef

Gold MS, Gebhart GF (2010) Nociceptor sensitization in pain pathogenesis. Nat Med 16(11):1248–1257. https://doi.org/10.1038/nm.2235 CrossRefPubMedPubMedCentral

Gregory N, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA (2013) An overview of animal models of pain: disease models and outcome measures. J Pain 14(11):1255–1269CrossRef

Gupta D, Jain DK (2017) Synthesis, antifungal and antibacterial activity of novel 1,2,4-triazole derivatives. J Adv Pharm Technol Res. 6:141–146. https://doi.org/10.4103/2231-4040.161515 CrossRef

Haegens A, Heeringa P, Suylen RJV, Steele C, Aratani Y et al (2009) Myeloperoxidase deficiency attenuates Lipopolysaccharide-induced acute lung inflammation and subsequent citokyne and chemokine production. J Immunol 182(12):7990–7996CrossRef

Hagmann WK (2008) The many roles for fluorine in medicinal chemistry. J Med Chem 51:4359–4369. https://doi.org/10.1021/jm800219f CrossRefPubMed

Hanskaar S, Hole K (1987) The formalin test in mice: dissociation between in- flammatory and non-inflammatory pain. J Pain. 30(1):103–114. https://doi.org/10.1016/0304-3959(87)90088-1 CrossRef

http://www.iasp-pain.org/Taxonomy. Pain terms, a current list with definitions and notes on usage (pp 209–214). Classification of Chronic Pain, Second Edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle, ©1994

Hunashal RD, Ronad PM, Maddi VS, Satyanarayana D, Kamadod MA (2014) Synthesis, anti-inflammatory and analgesic activity of 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-ylthio] acetic acid derivatives. Arab J Chem 7(6):1070–1078. https://doi.org/10.1016/j.arabjc.2011.01.003 CrossRef

Jage J (2005) Opioid tolerance and dependence. Do they matter?. Eur J Pain 9:157–162. https://doi.org/10.1016/j.ejpain.2004.11.009 CrossRefPubMed

Ji RR, Xu ZZ, Gao YJ (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13:533–538. https://doi.org/10.1038/nrd4334 CrossRefPubMedPubMedCentral

Joanna L, Talarek S, Orzelska J, Fidecka S, Wujec M, Plech T (2014) The antinociceptive effect of 4-substituted derivatives of 5-(4-chlorophenyl)-2-(morpholin-4-ylmethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in mice. Naunyn-Schmiedeberg’s Arch Pharmacol 387:367–375. https://doi.org/10.1007/s00210-013-0938-0 CrossRef

Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203–210. https://doi.org/10.1038/35093019 CrossRefPubMed

Kawabata A (2001) Prostaglandin E2 and pain—an update. Biol Pharm Bull 34(8):1170–1173CrossRef

Khanage SG, Raju A, Mohite PB, Pandhare RB (2013) Analgesic activity of some 1,2,4-triazole heterocycles clubbed with pyrazole, tetrazole, isoxazole and pyrimidine. Adv Pharm Bull 3(1):13–18. https://doi.org/10.5681/apb.2013.003 CrossRef

Klebanoff SJ (2005) Myeloperoxidase: a friend and foe. J Leuk Biol 77:598–625CrossRef

Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412

L’abbé G, Bruynseels M, Delbeke P, Topper S (1990) Molecular rearrangements of 4-iminomethyl-1,2,3-triazoles replacement of 1-aryl substituents in 1H-1,2,3-triazoles-4-carbaldehydes. J Heterocycl Chem 27:2021CrossRef

Li J, Zhang J, Rodrigues MC, Ding D, Longo JPF et al (2016) Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity. Bioorg Med Chem Lett 26(16):3881–3885. https://doi.org/10.1016/j.bmcl.2016.07.017 CrossRefPubMed

Lima LM, Barreiro EJ (2005) Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 12:23–49CrossRef

Ma W, Quirion R (2007) Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 11(3):307–320CrossRef

Meotti FC, Coelho IS, Santos ARS (2010) The nociception induced by glutamate in mice is potentiated by protons released into solution. J Pain 11(6):570–578. https://doi.org/10.1016/j.jpain.2009.09.012 CrossRefPubMed

Mickle AD, Shepherd AJ, Mohapatra DP (2016) Nociceptive TRP channels: sensory detectors and transducers in multiple pain pathologies. J Pharm 9:72. https://doi.org/10.3390/ph9040072 CrossRef

Mohd Sani MH, Zakaria ZA, Balan T, The LK, Salleh MZ (2012) Antinociceptive activity of methanol extract of Muntingia calabura leaves and the mechanisms of action involved. J Evid Based Complement Altern Med 2012:1–10. https://doi.org/10.1155/2012/890361 CrossRef

Montes GC, Silva BNM, Rezende B, Sudo RT, Ferreira VF (2017) The hypnotic, anxiolytic, and antinociceptive profile of a novel μ-opioid agonist. Molecules 22:800. https://doi.org/10.3390/molecules22050800 CrossRefPubMedCentral

Moore AR (2003) Pleural models of inflammation: immune and noimmune. In: Winyard PG, Willoughby DA (eds) Inflammation protocols. Humana Press, Totowa, pp 123–128CrossRef

Nourshargh S, Alon R (2014) Leukocyte migration into inflamed tissues. Immunity. https://doi.org/10.1016/j.immuni.2014.10.008 CrossRefPubMed

Oliveira LP, Silva DPB, Florentino IF, Fajemiroye JO, Oliveira TS et al (2016) New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole:synthesis and assessment of some biological activities. Chem Biol Drug Des. https://doi.org/10.1111/cbdd.12838 CrossRefPubMed

Oliveira-Junior JO, Portela Junior CSA, Cohen CP (2016) Inflammatory mediators of neuropathic pain. Sociedade Brasileira para o Estudo da Dor 17(Suppl 1):S35–S42. https://doi.org/10.5935/1806-0013.20160045 CrossRef

Passos GF, Fernandes ES, da Cunha FM, Ferreira J, Pianowski LF et al (2007) Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J Ethnopharmacol 110(2):323–333CrossRef

Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S et al (2009) Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways. Bioorg Med Chem 17:6442–6450. https://doi.org/10.1016/j.bmc.2009.07.007 CrossRefPubMed

Penthala NR, Madhukuri L, Thakkar S, Madadi NR, Lamture G et al (2015) Synthesis and anti-cancer screening of novel heterocyclic-Ĳ2H)-1,2,3-triazoles as potential anticancer agents. Med Chem Commun J 6:1535–1543. https://doi.org/10.1039/C5MD00219B CrossRef

Porreca F, Ossipov MH (2009) Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med 10(4):654–662. https://doi.org/10.1111/j.1526-4637.2009.00583.x CrossRefPubMed

Portman R (1998) WO Patent 9802423

Rajkapoor B, Kavimani S, Ravichandiran V, Sekhar K, Senthil Kumar R et al (2009) Effect of Indigofera aspalathoides on complete Freund’s adjuvant-induced arthritis in rats. Pharm Biol 47(6):553–557. https://doi.org/10.1080/13880200902902489 CrossRef

Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Thér 4:409–419

Rios ERV, Rocha NFM, Carvalho AMR, Vanconcelos LF, Dias ML et al (2013) TRP and ASIC channels mediate the antinociceptive effect of citronellyl acetate. Chem Biol Interact 203:573–579. https://doi.org/10.1016/j.cbi.2013.03.014 CrossRefPubMed

Roschangar F, Sheldon RA, Senanayake CH (2015) Overcoming barriers to green chemistry in the pharmaceutical industry—the Green Aspiration LevelTM concept. Green Chem 17:752–758. https://doi.org/10.1039/c4gc01563k CrossRef

Sakurada T, Katsumata K, Tan-No K, Sakurada S, Kisara K (1992) The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacol J 31:1279–1285CrossRef

Saleh TSF, Calixto JB, Medeiros YS (1999) Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20(8):949–956CrossRef

Sedgwick AD (1995) Initiation of inflammatory response and its prevention. In: Bonta IL, Bray MA (eds) EUA: handbook of inflammation. Elsevier, New York, p 253

Sehgal N, Smith H, Manchikanti L (2011) Peripherally acting opioids and clinical implications for pain control. Pain Physician 14:249–258PubMed

Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38(3):347–352CrossRef

Sokal RR, Rohlf FJ (1981) Biometry: the principles and practice of statistics in biological research. W.H. Freeman and Co., New York

Trost BM (1991) The atom economy–a search for synthetic efficiency. Science 254:1471CrossRef

Tsuchida K, Ibuki T, Matsumura K (2015) Bromoenol lactone, an inhibitor of calcium-independent phospholipase A2, suppresses carrageenan-induced prostaglandin production and hyperalgesia in rat hind paw. Mediators Inflamm 2015:1–7. https://doi.org/10.1155/2015/605727 CrossRef

Vijayalaxmi A, Bakshi V, Begum N, Kowmudi V, Naveen Kumar NY, Reddy Y (2015) Anti-arthritic and anti inflammatory activity of beta caryophyllene against Freund’s complete adjuvant induced arthritis in wistar rats. Bone Rep Recomm 1:29. https://doi.org/10.4172/2469-6684.10009 CrossRef

Wang J, Sánchez-Roselló M, Aceña JL, del Pozo C, Sorochinsky AE et al (2014) Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011). Chem Rev 114:2432–2506. https://doi.org/10.1021/cr4002879 CrossRefPubMed

Watanabe M, Ueda T, Shibata Y, Kumamoto N, Ugawa S (2015) The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. NeuroReport 26(3):173–178CrossRef

Wemmie JA, Taugher RJ, Kreple CJ (2013) Acid-sensing ion channels in pain and disease. Nat Rev Neurosci 14(7):461–471. https://doi.org/10.1038/nrn3529 CrossRefPubMedPubMedCentral

White JPM, Cibelli M, Fidalgo AR (2010) Role of transient receptor potential and acid-sensing ion channels in peripheral inflammatory pain. Anesthesiology 112:729–741CrossRef

Yet L (2018) Privileged structures in drug discovery medicinal chemistry and synthesis, 1st edn. Wiley, Hoboken

Zelová H, Hosek J (2013) TNF-a signalling and inflammation: interactions between old acquaintances. Inflamm Res 62:641–651. https://doi.org/10.1007/s00011-013-0633-0 CrossRefPubMed

Zwaagstra ME, Timmerman H, Tamura M, Tohma T, Wada Y et al (1997) Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists. J Med Chem 40(7):1075–1089. https://doi.org/10.1021/jm960628d CrossRefPubMed

Titel: Mechanisms involved in the antinociceptive and anti-inflammatory effects of a new triazole derivative: 5-[1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl]-1H-tetrazole (LQFM-096)
verfasst von: Carina S. Cardoso
Daiany P. B. Silva
Dayane M. Silva
Iziara F. Florentino
James O. Fajemiroye
Lorrane K. S. Moreira
José P. Vasconcelos
Germán Sanz
Boniek G. Vaz
Luciano M. Lião
Danilo da S. Lima
Fernanda Cristina A. dos Santos
Ricardo Menegatti
Elson A. Costa
Publikationsdatum: 06.02.2020
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 4/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-020-00685-8

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Accelerated ageing profile in inflammatory arthritis is unique and tissue compartment specific

Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats

Correction to: Appraisal of disease-modifying potential of amlodipine as an anti-arthritic agent: new indication for an old drug

Design, synthesis and pharmacological assessment of new pyrazole compounds

Retraction Note: Selected TLR7/8 agonist and type I interferon (IFN‑α) cooperatively redefine the microglia transcriptome